Construction and Preliminary Validation of the Chinese Assessment Scale for Zoster-associated Pain Based on the Delphi Method
- 4 February 2026
- journal article
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 2 (1) , 1-14
Abstract
This study aimed to develop and preliminarily validate a Chinese assessment scale for zoster-associated pain (ZAP) based on the Delphi method. A descriptive study was conducted. An initial item pool was developed based on domestic and international guidelines, expert consensus, and professional discussions related to ZAP. The Delphi method was employed in September 2023 to screen and revise the items, forming a preliminary version of the scale. From October 5, 2023, to January 31, 2024, a total of 209 patients with ZAP treated at the Department of Pain Management, The First Affiliated Hospital of Zhejiang University School of Medicine, were surveyed using this scale. Items were excluded using several criteria: standard deviation < 0.7 or coefficient of variation < 0.15 (dispersion trend method), correlation coefficient < 0.2 or non-significant differences (P > 0.05) (correlation analysis), non-significant differences (P > 0.05) (critical ratio method), and factor loadings < 0.4 or cross-loadings > 0.4 on multiple factors (exploratory factor analysis). Reliability was evaluated using internal consistency (Cronbach’s α), and validity was assessed through content and construct validity. Two rounds of Delphi expert consultation were conducted, involving 15 clinical pain specialists. A preliminary 16-item scale was developed based on threshold screening criteria. The response rate for both Delphi rounds was 100%, and the authority coefficients of experts were all > 0.7. Cronbach's α coefficients were 0.847 and 0.909 for the first and second rounds, respectively. Kendall’s W coefficients were 0.259 (χ² = 108.814, P < 0.001) and 0.291 (χ² = 74.130, P < 0.001) across the two rounds. Following item analysis of the 209 patient responses, 15 items were retained. The content validity of the scale was judged to be satisfactory by pain specialists. After further validity testing, 11 items were finally retained. The Kaiser-Meyer-Olkin (KMO) value was 0.837, and Bartlett’s test of sphericity was significant (P < 0.001). Exploratory factor analysis extracted three common factors, accounting for a cumulative variance contribution of 64.791%. The final Cronbach’s α coefficient was 0.808. The developed Chinese version of the ZAP assessment scale consists of 11 items across three dimensions, demonstrating good reliability, validity, and applicability.Keywords
This publication has 31 references indexed in Scilit:
- Development of a Model for Predicting the Effectiveness of Pulsed Radiofrequency on Zoster-Associated PainPain and Therapy, 2022
- The Delphi method at a glancePflege, 2021
- Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: Data from an integrated health care networkJournal of Infection, 2021
- Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United StatesClinical Infectious Diseases, 2020
- The Epidemiology of Herpes Zoster and Postherpetic Neuralgia in China: Results from a Cross-Sectional StudyPain and Therapy, 2019
- Postherpetic NeuralgiaNew England Journal of Medicine, 2014
- Herpes ZosterNew England Journal of Medicine, 2013
- Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)Pain, 2005
- Nurse practitioner practice and deployment: electronic mail Delphi studyJournal of Advanced Nursing, 2003
- The McGill Pain Questionnaire: Major properties and scoring methodsPain, 1975